Total Payments
$12,158
2024 Payments
$2,487
Companies
53
Transactions
479
Medicare Patients
1,747
Medicare Billing
$185,672
Payment Breakdown by Category
Food & Beverage$12,124 (99.7%)
Education$33.62 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,124 | 477 | 99.7% |
| Education | $33.62 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,131 | 85 | $0 (2024) |
| Novo Nordisk Inc | $1,233 | 71 | $0 (2024) |
| ABBVIE INC. | $1,042 | 44 | $0 (2024) |
| Lilly USA, LLC | $1,034 | 50 | $0 (2024) |
| Nevro Corp. | $617.78 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $488.67 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $475.01 | 16 | $0 (2024) |
| Amarin Pharma Inc. | $453.83 | 23 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $453.63 | 18 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $429.59 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,487 | 96 | Lilly USA, LLC ($375.65) |
| 2023 | $2,543 | 75 | Janssen Pharmaceuticals, Inc ($328.23) |
| 2022 | $3,394 | 126 | Janssen Pharmaceuticals, Inc ($751.65) |
| 2021 | $3,734 | 182 | Janssen Pharmaceuticals, Inc ($729.70) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROLOGY | ||||||
| 12/19/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: VACCINE | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ENDOCRINE AGENT | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $21.35 | General |
| 08/28/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.30 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 426 | 711 | $140,707 | $39,644 |
| 2022 | 6 | 413 | 774 | $155,016 | $44,885 |
| 2021 | 4 | 413 | 838 | $173,924 | $53,661 |
| 2020 | 8 | 495 | 873 | $178,762 | $47,482 |
Total Patients
1,747
Total Services
3,196
Medicare Billing
$185,672
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 389 | $98,806 | $27,928 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 227 | $39,271 | $11,175 | 28.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 21 | $1,239 | $183.00 | 14.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 40 | 53 | $530.00 | $180.73 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 21 | 21 | $861.00 | $177.27 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 438 | $111,252 | $31,608 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 230 | $39,790 | $12,341 | 31.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 11 | 24 | $1,200 | $393.20 | 32.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 33 | $1,353 | $262.16 | 19.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 19 | $1,121 | $178.47 | 15.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 28 | 30 | $300.00 | $103.13 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 191 | 499 | $126,564 | $38,998 | 30.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 159 | 265 | $45,845 | $14,258 | 31.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 25 | 25 | $1,025 | $235.02 | 22.9% |
| 81002 | Urinalysis, manual test | Office | 2021 | 38 | 49 | $490.00 | $170.52 | 34.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 486 | $123,444 | $31,001 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 152 | 242 | $41,866 | $10,863 | 25.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 29 | 29 | $9,425 | $4,147 | 44.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 12 | 12 | $780.00 | $731.76 | 93.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 25 | 25 | $1,025 | $236.28 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $660.00 | $188.76 | 28.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 44 | 50 | $500.00 | $172.53 | 34.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 15 | 18 | $1,062 | $142.30 | 13.4% |
About Robert Schonhoff, PA
Robert Schonhoff, PA is a Medical healthcare provider based in Bandera, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2016. The National Provider Identifier (NPI) number assigned to this provider is 1568817005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Schonhoff, PA has received a total of $12,158 in payments from pharmaceutical and medical device companies, with $2,487 received in 2024. These payments were reported across 479 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($12,124).
As a Medicare-enrolled provider, Schonhoff has provided services to 1,747 Medicare beneficiaries, totaling 3,196 services with total Medicare billing of $185,672. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Bandera, TX
- Active Since 05/03/2016
- Last Updated 10/25/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568817005
Products in Payments
- XARELTO (Drug) $1,994
- MOUNJARO (Drug) $545.35
- JARDIANCE (Drug) $542.32
- Ozempic (Drug) $514.35
- UBRELVY (Drug) $492.66
- Vascepa (Drug) $453.83
- Kerendia (Drug) $429.59
- Rybelsus (Drug) $383.92
- VRAYLAR (Drug) $375.55
- Omnia (Device) $314.43
- Senza (Device) $303.35
- BREZTRI (Drug) $281.01
- Korlym (Drug) $280.48
- TRELEGY ELLIPTA (Drug) $261.96
- TRINTELLIX (Drug) $223.67
- INSPIRE (Device) $209.01
- ADUHELM (Biological) $197.83
- Roszet (Drug) $182.95
- FREESTYLE LIBRE 3 (Device) $168.56
- Auvelity (Drug) $149.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.